Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Updates from Dexcom at ADA 2025, with Kevin Sayer


Listen Later

In this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, welcome Kevin Sayer, chief executive officer of Dexcom, for a candid conversation about the evolving landscape of continuous glucose monitoring (CGM). From Dexcom’s origins to the latest updates on G7 and the emerging Stelo app, the discussion traces the company's journey and innovation roadmap.

Sayer reflects on how sharing real-time glucose data transformed the diabetes management experience—making life safer not just for children but also for adults living independently, caregivers, and entire family networks. Dexcom’s emphasis on data transparency has laid the groundwork for a broader shift toward individualized care, especially for those with type 2 diabetes.

The episode dives into Dexcom’s growing footprint in type 2 diabetes management, with expanded coverage across the nation’s three largest pharmacy benefit managers. Sayer emphasizes that CGM is not just about preventing hypoglycemia in insulin users anymore—it’s a behavioral and educational tool. Patients can now “see” the impact of food choices, physical activity, and medication adherence in real time, prompting lifestyle changes that might otherwise take years of trial-and-error clinical encounters.

The hosts also explore the integration of AI-powered features like food recognition, enhancements in the Stelo app for wellness tracking, and the implications of new CGM algorithms as G7 expands to 15-day wear. Sayer addresses the unique needs of people with and without diabetes and the regulatory constraints in tailoring CGM algorithms to specific use cases.

In a lighter moment, Sayer shares his enthusiasm for Dexcom’s public-facing campaigns, including recent collaborations with Lance Bass and Nick Jonas as well as the company’s network of “Dexcom Warriors.”

Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others.


...more
View all episodesView all episodes
Download on the App Store

Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesBy Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

  • 4.6
  • 4.6
  • 4.6
  • 4.6
  • 4.6

4.6

10 ratings


More shows like Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

View all
NPR News Now by NPR

NPR News Now

14,365 Listeners

Diabetes Core Update by American Diabetes Association

Diabetes Core Update

108 Listeners

The Rich Roll Podcast by Rich Roll

The Rich Roll Podcast

11,809 Listeners

Juicebox Podcast: Type 1 Diabetes by Scott Benner

Juicebox Podcast: Type 1 Diabetes

1,593 Listeners

Diabetes Connections | Type 1 Diabetes by Stacey Simms

Diabetes Connections | Type 1 Diabetes

218 Listeners

Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,483 Listeners

AFP: American Family Physician Podcast by American Academy of Family Physicians

AFP: American Family Physician Podcast

707 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,336 Listeners

Core IM | Internal Medicine Podcast by Core IM Team

Core IM | Internal Medicine Podcast

1,095 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

7,967 Listeners

Annals On Call Podcast by American College of Physicians

Annals On Call Podcast

194 Listeners

The Huddle: Conversations with the Diabetes Care Team by Association of Diabetes Care & Education Specialists

The Huddle: Conversations with the Diabetes Care Team

37 Listeners

The Mel Robbins Podcast by Mel Robbins

The Mel Robbins Podcast

20,604 Listeners

Diabetech - Diabetes Tech, Research, News by Justin Eastzer

Diabetech - Diabetes Tech, Research, News

41 Listeners

On The Pen With Dave Knapp by Dave Knapp Man On The Mounjaro, Bleav

On The Pen With Dave Knapp

242 Listeners